Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor- by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions-Reference-Cited by-同舟云学术

Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor- by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions

Published:2014-02-26 Issue:5 Volume:29 Page:1011-1024
ISSN:0268-1161
Container-title:Human Reproduction
language:en
Short-container-title:Human Reproduction

Author:

Nenicu A.,Korbel C.,Gu Y.,Menger M. D.,Laschke M. W.

Publisher

Oxford University Press (OUP)

Subject

Obstetrics and Gynaecology,Rehabilitation,Reproductive Medicine

Link

http://academic.oup.com/humrep/article-pdf/29/5/1011/9544674/deu035.pdf

Reference55 articles.

1. PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis

2. Endometriosis: The Role of Neuroangiogenesis

3. Angiogenesis Assays: A Critical Overview

4. Pathogenesis of endometriosis: the role of genetics, inflammation and oxidative stress

5. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin II – AT1 receptor signalling regulates the plasminogen-plasmin system in human stromal endometrial cells increasing extracellular matrix degradation, cell migration and inducing a proinflammatory profile;Biochemical Pharmacology;2024-07

2. PPAR‐γ regulates the polarization of M2 macrophages to improve the microenvironment for autologous fat grafting;The FASEB Journal;2024-04-25

3. The role of peroxisome proliferator-activated receptors in endometriosis;Frontiers in Medicine;2024-04-16

4. Angiogenesis signaling in endometriosis: Molecules, diagnosis and treatment (Review);Molecular Medicine Reports;2024-01-18

5. Identification and validation of risk score model based on gene set activity as a diagnostic biomarker for endometriosis;Heliyon;2023-07